To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCL
Clinical trial NCT06072131 · RECRUITING
Trial details
- NCT number
- NCT06072131
- Sponsor
- Acrotech Biopharma Inc.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-04
- Primary completion
- 2030-07-01
- Enrollment
- 504
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.